A risk-based approach for leveraging AI in clinical trials

AI can strengthen a clinical trial without adding unnecessary regulatory risk. This paper applies the FDA's seven-step credibility framework to digital twins, shows how PROCOVA increases statistical power while preserving trial validity, and details the safeguards that make model execution repeatable, traceable, and audit-ready.